1. Home
  2. ILMN vs ACM Comparison

ILMN vs ACM Comparison

Compare ILMN & ACM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • ACM
  • Stock Information
  • Founded
  • ILMN 1998
  • ACM 1980
  • Country
  • ILMN United States
  • ACM United States
  • Employees
  • ILMN N/A
  • ACM N/A
  • Industry
  • ILMN Medical Specialities
  • ACM Military/Government/Technical
  • Sector
  • ILMN Health Care
  • ACM Consumer Discretionary
  • Exchange
  • ILMN Nasdaq
  • ACM Nasdaq
  • Market Cap
  • ILMN 16.0B
  • ACM 16.3B
  • IPO Year
  • ILMN 2000
  • ACM 2007
  • Fundamental
  • Price
  • ILMN $97.68
  • ACM $125.95
  • Analyst Decision
  • ILMN Buy
  • ACM Strong Buy
  • Analyst Count
  • ILMN 15
  • ACM 10
  • Target Price
  • ILMN $123.67
  • ACM $128.50
  • AVG Volume (30 Days)
  • ILMN 1.4M
  • ACM 787.6K
  • Earning Date
  • ILMN 11-03-2025
  • ACM 08-04-2025
  • Dividend Yield
  • ILMN N/A
  • ACM 0.83%
  • EPS Growth
  • ILMN N/A
  • ACM 147.22
  • EPS
  • ILMN 7.91
  • ACM 4.59
  • Revenue
  • ILMN $4,284,000,000.00
  • ACM $16,074,699,000.00
  • Revenue This Year
  • ILMN N/A
  • ACM $2.09
  • Revenue Next Year
  • ILMN $2.76
  • ACM $5.76
  • P/E Ratio
  • ILMN $12.29
  • ACM $27.31
  • Revenue Growth
  • ILMN N/A
  • ACM 1.50
  • 52 Week Low
  • ILMN $68.70
  • ACM $85.00
  • 52 Week High
  • ILMN $156.66
  • ACM $126.29
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 47.14
  • ACM 69.38
  • Support Level
  • ILMN $95.44
  • ACM $123.00
  • Resistance Level
  • ILMN $100.44
  • ACM $126.29
  • Average True Range (ATR)
  • ILMN 2.48
  • ACM 2.01
  • MACD
  • ILMN -0.41
  • ACM 0.08
  • Stochastic Oscillator
  • ILMN 38.49
  • ACM 95.50

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About ACM AECOM

Aecom is one of the largest global providers of design, engineering, construction, and management services. It serves a broad spectrum of end markets including infrastructure, water, transportation, and energy. Based in Los Angeles, Aecom has a presence in over 150 countries and employs 51,000. The company generated $16.1 billion in sales in fiscal 2024.

Share on Social Networks: